Tardive dyskinesia can affect many areas of your life, including your social life and self-confidence. Learning how to manage these effects can help improve your overall well-being and daily ...

Significantly increased risk for tardive dyskinesia seen with doses >75 mg/day at last prescription and as maximum dose. HealthDay News — Antipsychotics at doses >75 mg/day are associated with ...

Dyskinesia hampers the quality of life for most Parkinson's disease patients following several years of therapy. However, the severity of L-Dopa-induced dyskinesia (LID) varies between patients ...

Uncontrollable movements from tardive dyskinesia (TD) can put a strain on your daily life, physically and mentally. Developing a stress management routine, employing social strategies, and seeking ...

The FDA has approved Neurocrine Bioscience’s Ingrezza, the first ever licensed treatment for tardive dyskinesia or TD. The condition is characterised by uncontrollable movement of the body or ...

Introduction: In the advanced stages of Parkinson’s disease (PD), motor complications such as wearing-off and dyskinesia are problematic and vary daily. These symptoms need to be monitored precisely ...

1 Primary Ciliary Dyskinesia Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK Background Quality of life (QOL)-primary ciliary dyskinesia (PCD) is the first ...

Examples of this include benztropine for extrapyramidal symptoms (EPS) of antipsychotics, trazodone or sedative/hypnotics for antidepressant-induced insomnia, modafinil for oversedation of various ...

Movement disorders are neurological conditions in which patients manifest a diverse range of movement impairments. Distinct structures within the basal ganglia of the brain, an area involved in ...

This agreement includes the program required for the approval of mesdopetam as a treatment for levodopa-induced dyskinesia (LIDs) in patients with Parkinson's disease. EMA has reviewed the ...

or benztropine (Cogentin). Intermittent athetoid movements of the tongue were seen in this case only on DOPA. Moderate athetoid movements of all 4 extremities were exhibited by another (Case 17).